A Case of Right-Sided Infective Endocarditis Requiring AngioVac Debulking
Danielle Pawlichuk, Micah Pippin
TL;DR
This paper presents a rare case of right-sided heart infection that required a special procedure called AngioVAC debulking after antibiotics failed.
Contribution
The novelty lies in the use of AngioVAC debulking as an alternative treatment for antibiotic-resistant right-sided infective endocarditis.
Findings
The patient had right-sided infective endocarditis affecting the tricuspid valve.
Intravenous antibiotics were ineffective, necessitating AngioVAC debulking.
The case highlights the need for alternative therapies in complex endocarditis cases.
Abstract
Infective endocarditis is an uncommon but consequential disease process that occurs after damage to the cardiac endothelium. Management depends on location and infection severity, but it can typically be treated with intravenous antibiotics. Still, in more complex presentations, surgical intervention may be warranted. Here, we examine a case of right-sided infective endocarditis affecting the tricuspid valve in a patient with a history of intravenous drug use. The purpose of this paper is to examine a case of right-sided endocarditis refractory to intravenous antibiotics, resulting in the need for an alternative treatment modality using AngioVAC debulking.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsInfective Endocarditis Diagnosis and Management · Antimicrobial Resistance in Staphylococcus · Streptococcal Infections and Treatments